Nucleic Acids On-Demand World-Wide (NOW)

The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours.

The developed platform


should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.
Related Programs

Research and Technology Development

Department Of Defense


Agency: Department of Defense

Office: DARPA - Biological Technologies Office

Estimated Funding: $81,498


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
FedBizOpps Announcement

Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.

See the Eligibility Information section of the BAA for more information.

Full Opportunity Web Address:
https://www.fbo.gov/index?s=opportunity&mode=form&id=e7ed37766897192c136d2d69eb057525&tab=core&_cview=1

Contact:


Agency Email Description:
lstrong@usbr.gov

Agency Email:


Date Posted:
2019-10-16

Application Due Date:


Archive Date:
2020-02-08


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.






More Federal Domestic Assistance Programs


Unallied Management Projects | VHA Inpatient Medicine | Demonstration Grants for Domestic Victims of Severe Forms of Human Trafficking | Prevention Advocacy Resources and Data Exchange Program | Tree Assistance Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders